Journal of Internal Medicine Concepts & Practice >

2023 , Vol. 18 >Issue 01: 28 - 33

DOI: https://doi.org/10.16138/j.1673-6087.2023.01.009

Specification and implementation plan

Ruijin Hospital recommendations for diagnosis and treatment of novel coronavirus infection in chronic kidney disease population (2023)

Expand

Received date: 2023-01-06

  Online published: 2023-02-13

Fold

Cite this article

OUYANG Yan, CHEN Zijin, ZHANG Qianying, et al . Ruijin Hospital recommendations for diagnosis and treatment of novel coronavirus infection in chronic kidney disease population (2023)[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(01) : 28 -33 . DOI: 10.16138/j.1673-6087.2023.01.009

References

[1] National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: chronic kidney disease[EB/OL]. 2020. https://www.ncbi.nlm.nih.gov/books/NBK566142/.
[2] Palevsky PM, Radhakrishnan J, Townsend RR. COVID-19: issues related to acute kidney injury, glomerular disease, and hypertension[EB/OL]. 2022. https://www.uptodate.com/contents/covid-19-issues-related-to-acute-kidney-injury-glomerular-disease-and-hypertension#!.
[3] Palevsky PM, Radhakrishnan J. COVID-19: issues related to end-stage kidney disease[EB/OL]. 2022. https://www.uptodate.com/contents/covid-19-issues-related-to-end-stage-kidney-disease#!. .
[4] 国家卫生健康委办公厅, 国家中医药局综合司. 新型冠状病毒感染诊疗方案(试行第十版)[EB/OL]. 2023. http://www.gov.cn/zhengce/zhengceku/2023-01/06/57353 43/files/5844ce04246b431dbd322d8ba10afb48.pdf.
[5] Georgiades CS, Moore CJ, Smith DP. Differences of renal parenchymal attenuation for acutely obstructed and unobstructed kidneys on unenhanced helical CT: a useful secondary sign?[J]. AJR Am J Roentgenol, 2001, 176(4): 965-968.
[6] Li Z, Wu M, Yao JW, et al. Caution on kidney dysfunctions of COVID-19 patients[EB/OL]. 2020. https://www.medrxiv.org/content/10.1101/2020.02.08.20021212v2.
[7] Murakami N, Hayden R, Hills T, et al. Therapeutic advances in COVID-19[J]. Nat Rev Nephrol, 2023, 19(1):38-52.
[8] Hiremath S, McGuinty M, Argyropoulos C, et al. Prescribing nirmatrelvir/ritonavir for COVID-19 in advanced CKD[J]. Clin J Am Soc Nephrol, 2022, 17(8):1247-1250.
[9] El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment[J]. Kidney Int, 2022, 101(5): 883-894.
[10] Leventhal J, Angeletti A, Cravedi P. EPO in patients with COVID-19: more than an erythropoietic hormone[J]. Am J Kidney Dis, 2020, 76(3): 441.
[11] Caplin NJ, Zhdanova O, Tandon M, et al. Acute peritoneal dialysis during the COVID-19 pandemic at Bellevue Hospital in New York City[J]. Kidney360, 2020, 1(12): 1345-1352.
[12] Soomro QH, Mukherjee V, Amerling R, et al. Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: prone to complications?[J]. Perit Dial Int, 2021, 41(3): 328-332.
[13] Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19[J]. Lancet Respir Med, 2020, 8(7): 738-742.
Options
Outlines

/

〈 〉